Thursday, January 23, 2020
SK Plasma to Export Blood Product Technology to Indonesia
SK Plasma Goes Global
SK Plasma to Export Blood Product Technology to Indonesia
  • By Choi Moon-hee
  • September 2, 2019, 14:34
Share articles

Officials of SK Plasma, Indonesia’s Bio Pharma, the Red Cross of Indonesia and the Ministries of Health and Welfare of Korea and Indonesia pose for a commemorative photo shoot after a memorandum of understanding (MOU) was signed between SK Plasma and Bio Pharma and the Red Cross of Indonesia.

SK Plasma, an SK Group company specializing in blood products, announced on Sep. 1 that it has signed a three-party MOU with state-owned Indonesian pharmaceutical company Bio Pharma and the Indonesian Red Cross for production of blood plasma for Indonesia and technology transfer to its Indonesian partner.

This marked the first time that a Korean blood product company signed a contract to export technology to Indonesia. SK Plasma is Korea's only blood product producer which was spun off from SK Chemicals in 2015.

Under the MOU, SK Plasma will register its finished blood products in Indonesia and export them to Indonesia, produce Indonesian blood plasma at its plant in Andong, Korea, and transfer SK Plasma’s technology to Bio Pharma.

Blood products are nationally essential drugs used to treat inherent immunodeficiency diseases, hemophilia, and burns. However, due to high technological barriers to R&D and production and difficulties in securing stable raw materials from blood of healthy people, there are only about 30 blood product producers worldwide.